Reports
Global Orthobiologics Market Analysis, Share, Forecast: By Product: Demineralized Bone Matrices (DBM), Viscosupplementation, Bone Morphogenetic Protein, Plasma-rich Protein, Bone Marrow Aspirate Concentrate, Allografts, Others; By Type; By Application; By End Use; Regional Analysis; Competitive Landscape; 2024-2032
Global Orthobiologics Market Outlook
The global orthobiologics market is expected to grow at a CAGR of 4.6% in the forecast period of 2024-2032 to attain USD 9.52 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Improving Healthcare Infrastructure to Aid the Market Growth of Orthobiologics
Region-wise, North America is expected to be the leading market for orthobiologics in the forecast period of 2024-2032. This could be attributed to the prevalence of prominent players who promote quality care and regularly update strategies for product development. Furthermore, reimbursement policies and fusion enhancement products, combined with robust healthcare industry, has been propelling the market forward. Meanwhile, the market for orthobiologics is expected to grow at an exponential rate in the Asia Pacific region in the forecast period. Increasing awareness, both among doctors and patients of the benefits of these products, rising disposable incomes, and improving healthcare standards help grow the regional market. Enhancement of the healthcare infrastructure in the forecast period is expected to provide growth opportunities in the forecast period. Also, growing competition among key players leading to increasing product launches is also driving the market for orthobiologics forward.
Orthobiologics: Market Segmentation
Orthobiologics are substances that orthopaedic surgeons use to help and catalyse healing. Healing of broken bones and injured muscles, tendons, and ligaments are few of the areas these are used in. Orthobiologics consist of substances that naturally occur in the human body.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is segmented on the basis of product into:
- Demineralized Bone Matrices (DBM)
- Viscosupplementation
- Bone Morphogenetic Protein
- Plasma-rich Protein
- Bone Marrow Aspirate Concentrate
- Allografts
- Others
The market is divided by type into:
- Knee
- Ankle
- Hip
- Wrist and shoulder
- Spine
- Others
The market is segregated on the basis of application into:
- Osteoarthritis and Degenerative Arthritis
- Spinal Fusion
- Soft-Tissue Injuries
- Fracture Recovery
- Maxillofacial and Dental Applications
- Others
On the basis of end use, the market is bifurcated into:
- Hospitals, Orthopaedic Clinics, and Ambulatory Care Centres
- Dental Clinics and Facilities
- Research and Academic Institute
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Geriatric Population to Aid the Market Growth of Orthobiologics
Hip and knee replacement is expected to have risen and is expected to rise significantly in the coming years, being one of the main drivers of orthobiologics. Rising geriatric population and increased awareness about orthobiologics are easing the growth of this market. Hospitals are the leading market segment in terms of end use. This is due to increasing adoption of new procedures and the rise of high end as well as affordable hospitals. High patient turnaround and frequent readmissions push the segment share of hospitals. The supportive infrastructure that helps ensure the accuracy and reliability of the procedure is also driving the market forward. Further, increased investment in research and development and advanced technological innovations by the major market players is expected to push the market growth in the forecast period as well.
Key Industry Players in the Global Orthobiologics Market
The report gives a detailed analysis of the following key players in the global orthobiologics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Kuros Biosciences A.G.
- Bioventus LLC
- Smith & Nephew Plc
- Johnson & Johnson Services, Inc.
- Stryker Corporation
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Type, Application, End Use, Region |
| Breakup by Product | Demineralized Bone Matrices (DBM), Viscosupplementation, Bone Morphogenetic Protein, Plasma-rich Protein, Bone Marrow Aspirate Concentrate, Allografts, Others |
| Breakup by Type | Knee, Ankle, Hip, Wrist and shoulder, Spine, Others |
| Breakup by Application | Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications, Others |
| Breakup by End Use | Hospitals, Orthopedic Clinics, and Ambulatory Care Centres, Dental Clinics and Facilities, Research and Academic Institute, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Kuros Biosciences A.G., Bioventus LLC, Smith & Nephew Plc, Johnson & Johnson Services, Inc., Stryker Corporation, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Orthobiologics Market Analysis
8.1 Key Industry Highlights
8.2 Global Orthobiologics Historical Market (2018-2023)
8.3 Global Orthobiologics Market Forecast (2024-2032)
8.4 Global Orthobiologics Market by Product
8.4.1 Demineralized Bone Matrices (DBM)
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Viscosupplementation
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Bone Morphogenetic Protein
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.4.4 Plasma-rich Protein
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2023)
8.4.4.3 Forecast Trend (2024-2032)
8.4.5 Bone Marrow Aspirate Concentrate
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2018-2023)
8.4.5.3 Forecast Trend (2024-2032)
8.4.6 Allografts
8.4.6.1 Market Share
8.4.6.2 Historical Trend (2018-2023)
8.4.6.3 Forecast Trend (2024-2032)
8.4.7 Others
8.5 Global Orthobiologics Market by Type
8.5.1 Knee
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Ankle
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Hip
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2023)
8.5.3.3 Forecast Trend (2024-2032)
8.5.4 Wrist and shoulder
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2023)
8.5.4.3 Forecast Trend (2024-2032)
8.5.5 Spine
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2023)
8.5.5.3 Forecast Trend (2024-2032)
8.5.6 Others
8.6 Global Orthobiologics Market by Application
8.6.1 Osteoarthritis and Degenerative Arthritis
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Spinal Fusion
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Soft-Tissue Injuries
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.6.4 Fracture Recovery
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2023)
8.6.4.3 Forecast Trend (2024-2032)
8.6.5 Maxillofacial and Dental Applications
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2023)
8.6.5.3 Forecast Trend (2024-2032)
8.6.6 Others
8.7 Global Orthobiologics Market by End Use
8.7.1 Hospitals, Orthopedic Clinics, and Ambulatory Care Centres
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2023)
8.7.1.3 Forecast Trend (2024-2032)
8.7.2 Dental Clinics and Facilities
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2023)
8.7.2.3 Forecast Trend (2024-2032)
8.7.3 Research and Academic Institute
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2023)
8.7.3.3 Forecast Trend (2024-2032)
8.7.4 Others
8.8 Global Orthobiologics Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.2.3 Breakup by Country Kingdom
9.2.3.1 United
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Kuros Biosciences A.G.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Bioventus LLC
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Smith & Nephew Plc
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Johnson & Johnson Services, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Stryker Corporation
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Orthobiologics Market: Key Industry Highlights, 2018 and 2032
2. Global Orthobiologics Historical Market: Breakup by Product (USD Billion), 2018-2023
3. Global Orthobiologics Market Forecast: Breakup by Product (USD Billion), 2024-2032
4. Global Orthobiologics Historical Market: Breakup by Type (USD Billion), 2018-2023
5. Global Orthobiologics Market Forecast: Breakup by Type (USD Billion), 2024-2032
6. Global Orthobiologics Historical Market: Breakup by Application (USD Billion), 2018-2023
7. Global Orthobiologics Market Forecast: Breakup by Application (USD Billion), 2024-2032
8. Global Orthobiologics Historical Market: Breakup by End Use (USD Billion), 2018-2023
9. Global Orthobiologics Market Forecast: Breakup by End Use (USD Billion), 2024-2032
10. Global Orthobiologics Historical Market: Breakup by Region (USD Billion), 2018-2023
11. Global Orthobiologics Market Forecast: Breakup by Region (USD Billion), 2024-2032
12. North America Orthobiologics Historical Market: Breakup by Country (USD Billion), 2018-2023
13. North America Orthobiologics Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Europe Orthobiologics Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Europe Orthobiologics Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Asia Pacific Orthobiologics Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Asia Pacific Orthobiologics Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Latin America Orthobiologics Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Latin America Orthobiologics Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Middle East and Africa Orthobiologics Historical Market: Breakup by Country (USD Billion), 2018-2023
21. Middle East and Africa Orthobiologics Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Global Orthobiologics Market Structure
Key Questions Answered in the Report
The global orthobiologics market is projected to grow at a CAGR of 4.6% between 2024 and 2032.
The major drivers of the market include the increased awareness, increasing adoption of new procedures, rise of high end and affordable hospitals, supportive infrastructure, increased investment in research and development and advanced technological innovations.
Rise in hip and knee replacement cases and rising geriatric population are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The market is segmented on the basis of product into demineralized bone matrices (DBM), Visco supplementation, bone morphogenetic protein, plasma-rich protein, bone marrow aspirate concentrate, and allografts, among others.
The market is divided by type into knee, ankle, hip, wrist and shoulder, and spine, among others.
The major applications are osteoarthritis and degenerative arthritis, spinal fusion, soft-tissue injuries, fracture recovery, maxillofacial and dental applications, among others.
The end-uses are hospitals, orthopedic clinics, and ambulatory care centres, dental clinics and facilities, research and academic institute, among others.
The major players in the industry are Kuros Biosciences A.G., Bioventus LLC, Smith & Nephew Plc, Johnson & Johnson Services, Inc., and Stryker Corporation, among others.
Analyst Review
The global orthobiologics market was driven by the rise in hip and knee replacement cases in the historical period. Aided by increasing adoption of new procedures and rising geriatric population, the market is expected to witness further growth in the forecast period of 2024-2032, growing at a CAGR of 4.6%.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The market is segmented on the basis of product into demineralized bone matrices (DBM), Visco supplementation, bone morphogenetic protein, plasma-rich protein, bone marrow aspirate concentrate, and allografts, among others. The market is divided by type into knee, ankle, hip, wrist and shoulder, and spine, among others. The major applications are osteoarthritis and degenerative arthritis, spinal fusion, soft-tissue injuries, fracture recovery, maxillofacial and dental applications, among others. The end-uses are hospitals, orthopedic clinics, and ambulatory care centres, dental clinics and facilities, research and academic institute, among others. The major regional markets for orthobiologics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The major players in the industry are Kuros Biosciences A.G., Bioventus LLC, Smith & Nephew Plc, Johnson & Johnson Services, Inc., and Stryker Corporation, among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER